Inactive Instrument

Cangene Corporation Stock

CNJ

CA13758B1022

News in other languages: Cangene Corporation

13-02-20	IPSEN : et Inspiration finalisent la vente d'IB1001 à Cangene Corporation
13-02-06	IPSEN : cède les droits mondiaux de l'IB1001 à Cangene

More news

Emergent BioSolutions Canada Inc is a Canada-based biopharmaceutical company in the business of developing, manufacturing, and commercializing products and technologies for global markets. It operates in two segments: biopharmaceutical operations and contract services. The biopharmaceutical operations segment consist of sales of approved products and non- specialty plasma. The contract-services segment consists of third-party contract-manufacturing revenues at the Company's Winnipeg facilities, as well as at Cangene bioPharma in Baltimore. It also provides commercial contract-manufacturing services, primarily through a United States-based subsidiary. The Company's products include Rho(D) Immune Globulin (Human) for Injection (WinRho) SDF, Hepatitis B Immune Globulin (Human) Injection (HepaGam B) and Varicella Zoster Immune Globulin (Human) (VariZIG).

Employees

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

13-12-13	Cangene Corporation : 12/13/2013 Cangene Reports First Quarter 2014 Results and Election of Directors	PU
13-12-11	Cangene Corporation : 12/11/2013 Cangene To Be Acquired By Emergent BioSolutions For US$222 Million	PU
13-07-29	Cangene Corporation : FDA lifts clinical hold on Cangene's hemophilia compound IB1001	PU
13-06-05	Cangene Corporation : Cangene Reports Third Quarter 2013 Results	PU
12-04-11	Cangene Corp : Further Senior Management Change at Cangene	PU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANGENE CORPORATION	-.--%	+1.69%	-	-	0
REGENERON PHARMACEUTICALS, INC.	+0.63%	-3.06%	+16.18%	-9.78%	66.74B
UCB	+1.23%	+2.80%	+37.51%	+202.14%	53.32B
SAMSUNG BIOLOGICS CO.,LTD.	+10.08%	+51.80%	+51.80%	+51.80%	48.12B
CSL LIMITED	-1.32%	-7.38%	-57.63%	-57.10%	38.25B
BIOGEN INC.	+0.78%	-1.84%	+52.49%	-27.01%	29.85B
INCYTE CORPORATION	+0.84%	+0.36%	+66.93%	+85.42%	23.51B
MODERNA, INC.	-5.17%	-12.54%	+58.98%	-56.04%	21.45B
INNOVENT BIOLOGICS, INC.	-1.21%	+1.12%	+1.98%	+170.93%	19.97B
SWEDISH ORPHAN BIOVITRUM AB	-0.22%	-0.95%	+61.97%	+123.78%	16.38B
Average	+1.16%	-1.00%	+32.25%	+53.79%	35.29B
Weighted average by Cap.	+1.81%	-0.11%	+27.80%	+49.98%

Cangene Corporation Stock

Stocks

CNJ

CA13758B1022

Pharmaceuticals

Press Releases: Cangene Corporation

News in other languages: Cangene Corporation

Biopharmaceuticals

Company Profile